GYRE - GYRE THERAPEUTICS, INC.

7.83
-0.450   -5.747%

Share volume: 323,479
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$8.28
-0.45
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
49%
Profitability 48%
Dept financing 29%
Liquidity 75%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-10.62%
1 Month
-0.63%
3 Months
-4.04%
6 Months
-0.76%
1 Year
-26.82%
2 Year
-62.14%
Key data
Stock price
$7.83
P/E Ratio 
108.03
DAY RANGE
$7.73 - $9.14
EPS 
$0.08
52 WEEK RANGE
$6.11 - $12.62
52 WEEK CHANGE
-$24.13
MARKET CAP 
718.496 M
YIELD 
N/A
SHARES OUTSTANDING 
96.333 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-12-2025
BETA 
1.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$138,602
AVERAGE 30 VOLUME 
$86,195
Company detail
CEO: Han Ying
Region: US
Website: www.gyretx.com
Employees: 40
IPO year: 2015
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA.

Recent news